The Claim

Apigenin inhibits compound 48/80-induced systemic anaphylaxis in mice.

Source: Apigenin Inhibits the Expression of IL-6, IL-8, and ICAM-1 in DEHP-Stimulated Human Umbilical Vein Endothelial Cells and In Vivo

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
12score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Apigenin reduces the severity of systemic allergic reactions triggered by compound 48/80 in mice.

See the scientific wording

Apigenin inhibits compound 48/80-induced systemic anaphylaxis in mice, suggesting a potential protective effect against acute allergic reactions in vivo.

Why this might work

Apigenin blocks a specific stress signal in blood vessel cells that triggers inflammation, which reduces the release of chemicals that activate immune cells and cause severe allergic reactions throughout the body.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Apigenin Inhibits the Expression of IL-6, IL-8, and ICAM-1 in DEHP-Stimulated Human Umbilical Vein Endothelial Cells and In Vivo

    In mice, a natural compound called apigenin was shown to reduce the severity of a severe allergic reaction triggered by a chemical, meaning it might help protect against allergic shocks.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.